首页> 外国专利> Analgesic composition in parenteral dosage Unit form or in a Unit dosage form suitable for administration by the dermis or mucosa comprising buprenorphine and naltRexona, useful for the treatment of pain.

Analgesic composition in parenteral dosage Unit form or in a Unit dosage form suitable for administration by the dermis or mucosa comprising buprenorphine and naltRexona, useful for the treatment of pain.

机译:肠胃外剂量单位形式或适于通过真皮或粘膜给药的单位剂量形式的止痛组合物,其包含丁丙诺啡和纳曲酮,可用于治疗疼痛。

摘要

An analgesic composition, in parenteral unit dosage form or in a unit dosage form suitable for delivery via the dermis or mucosa, comprises buprenorphine and an amount of naltrexone such that the ratio by weight of buprenorphine to naltrexone delivered to or reaching the plasma of a patient is in the range 100:1 to 5000:1. The analgesic action of the buprenorphine is potentiated by the low dose of naltrexone. Also provided are a method of treatment of pain and the use of buprenorphine and naltrexone for the manufacture of a medicament.
机译:肠胃外单位剂型或适于通过真皮或粘膜递送的单位剂型的镇痛组合物包含丁丙诺啡和一定量的纳曲酮,使得丁丙诺啡与纳曲酮的重量比被递送至或到达患者血浆。范围为100:1至5000:1。低剂量的纳曲酮可增强丁丙诺啡的镇痛作用。还提供了一种治疗疼痛的方法以及丁丙诺啡和纳曲酮在制备药物中的用途。

著录项

  • 公开/公告号CL2008000608A1

    专利类型

  • 公开/公告日2008-10-03

    原文格式PDF

  • 申请/专利权人 RB PHARMACEUTICALS LIMITED.;

    申请/专利号CL20080000608

  • 发明设计人 CHAPLEO CHRISTOPHER BOURNE HYDE NEIL;

    申请日2008-02-28

  • 分类号A61K45/06;A61P25/04;

  • 国家 CL

  • 入库时间 2022-08-21 20:08:33

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号